|Articles|June 19, 2020

Racial Disparities in Coronavirus Incidence, Knowledge, and Exposure

In a recent US survey, African American male participants knew more people infected with COVID-19, had greater knowledge disparities, and were exposed to the virus more than other groups.

A recent US survey showed African American men were more likely to know someone infected by coronavirus 2019 (COVID-19), had a greater knowledge disparity of how the virus spread, and were more likely to be exposed to the virus.

Marcella Alsan, MD, MPH, PhD, associate professor of medicine, Stanford University, led a team of investigators who developed the survey and analyzed the results. The survey’s findings were reported in JAMA.

The electronic survey was conducted between March 29 and April 13. There were 5198 total respondents, with 2336 men and 2850 women. There were 3759 white, 830 African Americans, and 609 Hispanic respondents. The survey respondent needed to be 18 years or older, and to have been living in the US.

The investigators pointed out that younger African American men were at the greatest risk to COVID-19.

“The largest differences in COVID-19—related knowledge and behaviors were associated with race/ethnicity, sex, and age, with African American participants, men, and people younger than 55 years showing less knowledge than other groups,” Alsan and collaborators wrote.

Overall, African American respondents were more likely to report COVID-19 infection by a mean 3.5 percentage points (95% CI, 1.5-5.5; P = .001) than white respondents.

Men of all ethnicities were also more likely than women to report COVID-19 infection, by a mean 3.2 percentage points (95% CI, 2.0-4.4; P <.001).

Findings confirmed racial disparities in looking at COVID-19.

For example, African American respondents were less likely to know about fomite transmission, asymptomatic transmission, respiratory droplet transmission or the 3 common symptoms of COVID-19.

In terms of exposure, African American men were more likely to leave the house. The investigators surmised the differences might stem from socioeconomics.

“African American individuals are less likely to be able to telecommute and more likely to work in the service sector and use public transportation than other racial/ethnic groups (23% among African American individuals vs 15% among Hispanic individuals and 7% among white individuals),” investigators wrote.

Looking at these findings, the team saw a correlation between behaviors and knowledge.

“Groups in which behaviors put people more at risk for disease were also groups in which knowledge of appropriate behaviors are weakest,” Alsan and collaborators wrote. “These findings suggest that greater efforts to communicate risk and safe practices to racial/ethnic minorities and younger people may be particularly crucial moving forward.”

Survey limitations included accessibility to the survey with it being electronic and thus possibly being limited to those with Internet access. The other limitation the authors noted was the changing information associated with knowledge and behaviors.

“These findings confirm anecdotal reports of concerning gaps in reported prevalence and knowledge regarding COVID-19 across demographic characteristics in the US population,” the authors concluded. “More effort will be needed to address the knowledge and behavior gaps between white and African American individuals, between men and women, and between older and younger populations.”


Related to this article

Measles Update: October 23, 2026
The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.